HRP20120002T1 - Liječenje mastitisa - Google Patents
Liječenje mastitisa Download PDFInfo
- Publication number
- HRP20120002T1 HRP20120002T1 HR20120002T HRP20120002T HRP20120002T1 HR P20120002 T1 HRP20120002 T1 HR P20120002T1 HR 20120002 T HR20120002 T HR 20120002T HR P20120002 T HRP20120002 T HR P20120002T HR P20120002 T1 HRP20120002 T1 HR P20120002T1
- Authority
- HR
- Croatia
- Prior art keywords
- mastitis
- indicated
- use according
- treatment
- enrofloxacin
- Prior art date
Links
- 208000004396 mastitis Diseases 0.000 title claims abstract 3
- SPFYMRJSYKOXGV-UHFFFAOYSA-N Baytril Chemical compound C1CN(CC)CCN1C(C(=C1)F)=CC2=C1C(=O)C(C(O)=O)=CN2C1CC1 SPFYMRJSYKOXGV-UHFFFAOYSA-N 0.000 claims abstract 3
- 229960000740 enrofloxacin Drugs 0.000 claims abstract 3
- 241000283690 Bos taurus Species 0.000 claims abstract 2
- 239000003814 drug Substances 0.000 claims abstract 2
- 238000001990 intravenous administration Methods 0.000 claims abstract 2
- 238000004519 manufacturing process Methods 0.000 claims abstract 2
- 229940079593 drug Drugs 0.000 claims 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/498—Pyrazines or piperazines ortho- and peri-condensed with carbocyclic ring systems, e.g. quinoxaline, phenazine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Gynecology & Obstetrics (AREA)
- Pregnancy & Childbirth (AREA)
- Tropical Medicine & Parasitology (AREA)
- Rheumatology (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Urology & Nephrology (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Cephalosporin Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE102004054873A DE102004054873A1 (de) | 2004-11-12 | 2004-11-12 | Behandlung von Mastitis |
PCT/EP2005/011553 WO2006050826A2 (de) | 2004-11-12 | 2005-10-28 | Behandlung von mastitis mit enrofloxacin |
Publications (1)
Publication Number | Publication Date |
---|---|
HRP20120002T1 true HRP20120002T1 (hr) | 2012-02-29 |
Family
ID=35462240
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HR20120002T HRP20120002T1 (hr) | 2004-11-12 | 2011-12-30 | Liječenje mastitisa |
Country Status (27)
Country | Link |
---|---|
US (2) | US20070265275A1 (xx) |
EP (1) | EP1812002B1 (xx) |
JP (2) | JP2008519781A (xx) |
KR (1) | KR20070084182A (xx) |
CN (1) | CN101056638A (xx) |
AR (1) | AR051763A1 (xx) |
AT (1) | ATE526970T1 (xx) |
BR (1) | BRPI0517473A (xx) |
CA (1) | CA2587187A1 (xx) |
CR (1) | CR9109A (xx) |
DE (2) | DE102004054873A1 (xx) |
DK (1) | DK1812002T3 (xx) |
ES (1) | ES2373449T3 (xx) |
HR (1) | HRP20120002T1 (xx) |
IL (1) | IL182993A (xx) |
MX (1) | MX2007005526A (xx) |
NO (1) | NO20072890L (xx) |
NZ (1) | NZ555062A (xx) |
PE (1) | PE20061139A1 (xx) |
PL (1) | PL1812002T3 (xx) |
PT (1) | PT1812002E (xx) |
RU (1) | RU2413514C2 (xx) |
SI (1) | SI1812002T1 (xx) |
SV (1) | SV2006002296A (xx) |
UA (1) | UA92593C2 (xx) |
WO (1) | WO2006050826A2 (xx) |
ZA (1) | ZA200703695B (xx) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP5217276B2 (ja) * | 2007-07-19 | 2013-06-19 | ニプロ株式会社 | 注射用抗菌剤の製造方法 |
GB2480276A (en) * | 2010-05-11 | 2011-11-16 | Michael Hilary Burke | Process for the preparation of an aqueous injectable enrofloxacin antimicrobial formulation |
CN101933927A (zh) * | 2010-06-30 | 2011-01-05 | 洛阳惠中兽药有限公司 | 一种含恩诺沙星六水合物组合物及其在制备治疗或预防家畜疾病的药物中的应用 |
CA2877794C (en) * | 2012-06-29 | 2020-08-04 | Bayer Animalhealth Gmbh | Pharmaceutical compositions and treatment of mastitis |
KR20150132325A (ko) * | 2013-03-15 | 2015-11-25 | 젠자임 코포레이션 | 아민 작용성 폴리아미드 |
RU2655772C1 (ru) * | 2016-12-26 | 2018-05-29 | Федеральное государственное бюджетное научное учреждение "Курский научно-исследовательский институт агропромышленного производства" | Йодсодержащий состав для лечения мастита у коров |
RU2652354C1 (ru) * | 2017-11-07 | 2018-04-25 | федеральное государственное бюджетное образовательное учреждение высшего образования "Волгоградский государственный аграрный университет" (ФГБОУ ВО Волгоградский ГАУ) | Способ терапии коров, больных маститом |
CN108051512A (zh) * | 2017-11-27 | 2018-05-18 | 佛山科学技术学院 | 一种牛乳中氟喹诺酮类药物残留量的检测方法 |
CN110812326B (zh) * | 2019-11-04 | 2022-04-22 | 黑龙江省农业科学院畜牧兽医分院 | 一种辛伐他汀混悬乳剂及其制备方法和应用 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4670444B1 (en) * | 1980-09-03 | 1999-02-09 | Bayer Ag | and-naphthyridine-3-carboxylic acids and antibacte7-amino-1-cyclopropyl-4-oxo-1,4-dihydro-quinoline-rial agents containing these compounds |
DE3333719A1 (de) | 1983-09-17 | 1985-04-04 | Bayer Ag | Loesungen milchsaurer salze von piperazinylchinolon- und piperazinyl-azachinoloncarbonsaeuren |
DE3517709A1 (de) | 1985-01-05 | 1986-07-10 | Bayer Ag | Basische zubereitungen von chinoloncarbonsaeuren |
DE3537761A1 (de) * | 1985-10-24 | 1987-04-30 | Bayer Ag | Infusionsloesungen der 1-cyclopropyl-6-fluor-1,4-dihydro-4-oxo-7- (1-piperazinyl)-chinolin-3-carbonsaeure |
DE3713672A1 (de) | 1987-04-24 | 1988-11-17 | Bayer Ag | Verfahren zur herstellung von parenteral verabreichbaren chinoloncarbonsaeuren |
DE19500784A1 (de) | 1995-01-13 | 1996-07-18 | Bayer Ag | Enrofloxacin-Injektions- oder Infusionslösungen |
CA2176298C (en) * | 1995-06-27 | 2009-01-27 | Dennis D. Copeland | A single high dose fluoroquinolone treatment |
-
2004
- 2004-11-12 DE DE102004054873A patent/DE102004054873A1/de not_active Withdrawn
-
2005
- 2005-10-28 BR BRPI0517473-2A patent/BRPI0517473A/pt not_active IP Right Cessation
- 2005-10-28 MX MX2007005526A patent/MX2007005526A/es unknown
- 2005-10-28 CA CA002587187A patent/CA2587187A1/en not_active Abandoned
- 2005-10-28 ES ES05800007T patent/ES2373449T3/es active Active
- 2005-10-28 WO PCT/EP2005/011553 patent/WO2006050826A2/de active Application Filing
- 2005-10-28 EP EP05800007A patent/EP1812002B1/de not_active Revoked
- 2005-10-28 KR KR1020077010702A patent/KR20070084182A/ko not_active Application Discontinuation
- 2005-10-28 DE DE202005022066U patent/DE202005022066U1/de not_active Expired - Lifetime
- 2005-10-28 RU RU2007121516/15A patent/RU2413514C2/ru not_active IP Right Cessation
- 2005-10-28 JP JP2007540532A patent/JP2008519781A/ja active Pending
- 2005-10-28 PT PT05800007T patent/PT1812002E/pt unknown
- 2005-10-28 UA UAA200706592A patent/UA92593C2/ru unknown
- 2005-10-28 CN CNA2005800384782A patent/CN101056638A/zh active Pending
- 2005-10-28 NZ NZ555062A patent/NZ555062A/en not_active IP Right Cessation
- 2005-10-28 AT AT05800007T patent/ATE526970T1/de active
- 2005-10-28 DK DK05800007.6T patent/DK1812002T3/da active
- 2005-10-28 PL PL05800007T patent/PL1812002T3/pl unknown
- 2005-10-28 US US11/718,999 patent/US20070265275A1/en not_active Abandoned
- 2005-10-28 SI SI200531440T patent/SI1812002T1/sl unknown
- 2005-11-11 SV SV2005002296A patent/SV2006002296A/es unknown
- 2005-11-11 PE PE2005001315A patent/PE20061139A1/es not_active Application Discontinuation
- 2005-11-11 AR ARP050104723A patent/AR051763A1/es unknown
-
2007
- 2007-05-03 IL IL182993A patent/IL182993A/en not_active IP Right Cessation
- 2007-05-08 ZA ZA200703695A patent/ZA200703695B/xx unknown
- 2007-05-09 CR CR9109A patent/CR9109A/es unknown
- 2007-06-06 NO NO20072890A patent/NO20072890L/no not_active Application Discontinuation
-
2011
- 2011-12-30 HR HR20120002T patent/HRP20120002T1/hr unknown
-
2012
- 2012-09-21 US US13/624,179 patent/US20130023540A1/en not_active Abandoned
- 2012-11-02 JP JP2012242959A patent/JP2013063985A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
DK1812002T3 (da) | 2012-02-06 |
JP2013063985A (ja) | 2013-04-11 |
AR051763A1 (es) | 2007-02-07 |
ZA200703695B (en) | 2008-08-27 |
KR20070084182A (ko) | 2007-08-24 |
US20070265275A1 (en) | 2007-11-15 |
DE102004054873A1 (de) | 2006-05-18 |
IL182993A (en) | 2013-03-24 |
ATE526970T1 (de) | 2011-10-15 |
PT1812002E (pt) | 2011-12-30 |
NZ555062A (en) | 2009-12-24 |
UA92593C2 (xx) | 2010-11-25 |
RU2007121516A (ru) | 2008-12-20 |
DE202005022066U1 (de) | 2012-12-06 |
US20130023540A1 (en) | 2013-01-24 |
PL1812002T3 (pl) | 2012-03-30 |
NO20072890L (no) | 2007-06-06 |
CA2587187A1 (en) | 2006-05-18 |
JP2008519781A (ja) | 2008-06-12 |
IL182993A0 (en) | 2007-09-20 |
PE20061139A1 (es) | 2006-12-29 |
MX2007005526A (es) | 2007-07-09 |
RU2413514C2 (ru) | 2011-03-10 |
CN101056638A (zh) | 2007-10-17 |
SI1812002T1 (sl) | 2012-03-30 |
SV2006002296A (es) | 2006-06-26 |
BRPI0517473A (pt) | 2008-10-07 |
EP1812002B1 (de) | 2011-10-05 |
CR9109A (es) | 2007-10-04 |
ES2373449T3 (es) | 2012-02-03 |
WO2006050826A2 (de) | 2006-05-18 |
EP1812002A2 (de) | 2007-08-01 |
WO2006050826A3 (de) | 2006-07-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HRP20120002T1 (hr) | Liječenje mastitisa | |
RS51688B (en) | METHOTREXATE CONCENTRATED SOLUTIONS | |
RS52831B (en) | THIN BUPRENORPHINE TILES FOR DRUG REPLACEMENT THERAPY | |
IL197393A (en) | History of pyridine-4-ram, containing and using pharmaceutical preparations for the preparation of drugs for the treatment of immune-related diseases | |
NZ593199A (en) | Milnacipran for the long-term treatment of fybromyalgia syndrome | |
ATE464883T1 (de) | Geschmacksabdeckende formulierung mit einer retardierten wirkstoffformulierung und/oder schnell löslichem cyclodextrin | |
ES2175415T3 (es) | Inhibidores de metaloproteasas matriciales basados en fosfinato. | |
HRP20150889T1 (hr) | Postupci za lijeäśenje adhezivnog kapsulitisa | |
NO20042364L (no) | Formulering av aminosyrer og riboflavin nyttig for a redusere toksiske effekter av cytotoksisk kjemoterapi | |
EA200501203A1 (ru) | Жидкие фармацевтические композиции палоносетрона | |
WO2006050002A3 (en) | Compositions for controlled delivery of pharmaceutically active compounds | |
UA96622C2 (ru) | Твердые лекарственные формы, которые содержат алискирен, изготовленные способом сухого гранулирования | |
FI3071563T3 (fi) | Syövän vastaisia aineita ja niiden valmistus | |
WO2022261240A3 (en) | Dimethoxyphenylalkylamine activators of serotonin receptors | |
WO2012035561A3 (en) | Improved oral targetted drug delivery system | |
RU2007122391A (ru) | S-миртазапин для лечения приливов | |
WO2020243273A3 (en) | Methods of treating cholangiocarcinoma | |
WO2008008882A3 (en) | Glucocorticoid receptor modulator and methods of use | |
WO2007145863A3 (en) | Sustained release formulation of naltrexone | |
ATE410152T1 (de) | Therapeutisches system mit amoxicillin und clavulansäure | |
ATE551999T1 (de) | P-glycoprotein-hemmer mit octiloniumbromid als wirkstoff | |
WO2021101258A3 (ko) | 압타머 기반 표적화 복합 항암제 | |
WO2020190900A8 (en) | Abiraterone-cyclic oligomer pharmaceutical formulations and methods of formation and administration thereof | |
EA200701525A1 (ru) | Фармацевтическая полимерная композиция для перорального введения тербуталина сульфата с контролируемым высвобождением | |
MXPA06000760A (es) | Composicion farmaceutica estable de carisoprodol y meloxicam. |